marc bulterys, md, phd cdc country director (2008-13) china-us cooperation 中美合作 - ...
DESCRIPTION
Current HIV/AIDS Situation in China UCLA “HIV/AIDS Epidemiology” Course by Prof. Roger Detels November 27, 2013. Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目. Overview. Description of the HIV epidemic in China Ongoing challenges - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/1.jpg)
Current HIV/AIDS Situation in China
UCLA “HIV/AIDS Epidemiology” Course by Prof. Roger Detels
November 27, 2013
Marc Bulterys, MD, PhD CDC Country Director (2008-13)
China-US Cooperation 中美合作 - 全球艾滋病项目
1
![Page 2: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/2.jpg)
Overview
• Description of the HIV epidemic in China• Ongoing challenges• History of US-China cooperation on
HIV/AIDS
2
![Page 3: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/3.jpg)
National Targets by 2015
– Goals: • The number of people living with HIV/AIDS be controlled
to no more than 1,200,000
• New HIV infection 25%
• AIDS mortality 30%
– Measures:
• Prevention: 90% coverage for high-risk, 70% HIV testing
• ART: >80%
• PMTCT: >80%
3
![Page 5: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/5.jpg)
Overview of HIV Epidemic in China
Stable HIV incidence with ~50,000 new HIV infections per year (highest recent estimate in 2007: 70,000) 800,000-900,000 estimated PLHA (2013)
260,000 PLHIV eligible for ART at CD4<350 (2012) 164,000 and 63% eligible on ART; 80% of known (2012)
28,000 deaths due to HIV (2012)
2012 China AIDS Response Progress Report, China MOH; UNAIDS; NCAIDS (2013); personal communication
Population HIV Prevalence (2011) HIV incidence (2011)
General population 0.1% 48,000
Key populationsFSWMSMPWID
0.5%6.3%6.4%
0.1 per 100 pyrs3-6 per 100 pyrs0.2 per 100 pyrs (MMT); 1-3 per 100 pyrs outside
![Page 6: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/6.jpg)
HIV Prevalence in Key Populations
2012 China AIDS Response Progress Report, China MOH; from China’s HIV Sentinel Surveillance System
![Page 7: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/7.jpg)
HIV Prevalence Among MSM
2012 China AIDS Response Progress Report, China MOH
![Page 8: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/8.jpg)
Transmission Modes Change Overtime
Sexual83.2%
IDU MSM HeterosexualBloodMTCTUnknown
8
![Page 9: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/9.jpg)
MSM Account for 50% of Newly Reported HIV Cases in Provincial Capital Cities
IDUMSMHeterosexualBlood/productsMTCT
![Page 10: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/10.jpg)
10
Methadone Reduces HIV Incidence Among Drug Users
26%
![Page 11: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/11.jpg)
October 29, 2010
11
![Page 12: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/12.jpg)
Key Populations: Opportunities and Barriers
All: Late treatment initiation, high mortality pre-ART FSW:
Barriers to accessing care and maintaining ART adherence Low-fee and rural FSWs have higher HIV/STI rates; in some cities
linked with heroin and amphetamine use MSM:
Increasing HIV transmission, limited intervention coverage in many cities and continuing stigma issues
PWID: Low ART coverage & treatment retention, high mortality & co-
morbidities. Need earlier HIV diagnosis & better ART access MMT clinics can be platforms for comprehensive HIV services,
including DOT ART
![Page 13: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/13.jpg)
National Free ART Program - 1
• National Free ART Program began in 2002 among former plasma donors
• Rapidly scaled up to cover entire country
13
![Page 14: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/14.jpg)
National Free ART Program - 2
• Currently over 200,000 patients from all high-risk groups on ART (AZT/TDF + 3TC + NVP/EFV)
• CD4 tests now routine; annual viral load tests recommended in 2009, gradually scaled up
• Second-line antiretroviral therapy introduced in 2008; currently >15,000 patients on second-line drugs (usually TDF+3TC+LPV/r)
14
![Page 15: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/15.jpg)
Five-Year Survival and Mortality Rates
Zhang F et al. Annals of Internal Medicine 200915
![Page 16: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/16.jpg)
ART Coverage Increases but Needs Further Expansion
Lancet Infectious Disease 2011: ART coverage 78% in FPD, 60% in sexual transmission population and only 39% in PWID 16
![Page 17: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/17.jpg)
17
Cascade of HIV Services in China (2012)
![Page 18: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/18.jpg)
8 pilot counties in 2003
271 pilot counties in 2007
333 pilot counties in 2008
1156 pilot counties in 2010
(HIV+Syphilis+HBV)
Increase in Integrated PMTCT programs, 2003-2010
18
![Page 19: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/19.jpg)
Trends in MTCT of HIV in 15 Selected Counties in China, 2005-2009
Manuscript on trends in mother-to-child transmission of HIV-1 in China, NCWCH (submitted)
![Page 20: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/20.jpg)
Barriers and Challenges
~50% of PLHA are unaware of their HIV status Frequent late enrollment in care & ART initiation
![Page 21: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/21.jpg)
Barriers and Challenges
High burden among ethnic minorities: 8% of population but with 38% of HIV cases, often residing in rural and remote areas
Multi-sectorial collaboration to improve linkages between vertical health systems (MCH, CDC, MMT, hospital)
Limited involvement and capacity of civil society
Severe poverty and inequitable financing of basic health care in certain regions
![Page 22: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/22.jpg)
History of US-China Cooperation on HIV/AIDS
• CDC assessment mission to China in 2001• GAP office established in Beijing in Oct 2003• NIH CIPRA grant ended in 2010• Transition of USAID HIV/AIDS activities in Guangxi
and Yunnan to local government (2011)• Continued emphasis on technical collaboration
between US and China CDCs (2013-)
22
![Page 23: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/23.jpg)
Technical Collaboration Framework
• Goal• Strengthen partnership between US CDC and China
CDC for HIV/AIDS response within and beyond China
• Principles • Integration • Innovation • Evidence-based• Experience sharing • South-to-South cooperation
23
![Page 24: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/24.jpg)
Focus (high prevalence)
TA only (low prevalence, high risk and/or unique epidemics)
Previously supported
Rural AIDS Clinical Training Centers in Liangshan, Luzhai, and Lixin
Xinjiang
NingxiaQinghai
Tibet
Yunnan
Guizhou
Guangxi Guangdong
Inner Mongolia
Beijing
Heilongjiang
Shandong
JiangsuHenan
Anhui
US-China Cooperation Provinces (2003-2013)
24
![Page 25: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/25.jpg)
Support of Epidemiologic Data Analysis and Operational Research to Improve HIV/AIDS
Outcomes in China
![Page 26: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/26.jpg)
PMTCT and Community Mobilization
Increased use of antenatal care and hospital delivery services among minority women in Guangxi
26
![Page 27: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/27.jpg)
Rural AIDS Clinical Training Centers in three provinces
• Three training centers: – Lixin ( 利辛 ) , Anhui (2004) – Luzhai ( 鹿寨 ), Guangxi (2010) – Liangshan ( 凉山 ), Sichuan (2012)
• Transitioned Lixin center to local government in 2011
• Trained 229 rural physicians who are serving >20,000 patients on ART in 16 provinces by 08/31/13
27
![Page 28: Marc Bulterys, MD, PhD CDC Country Director (2008-13) China-US Cooperation 中美合作 - 全球艾滋病项目](https://reader036.vdocuments.net/reader036/viewer/2022081415/56813f63550346895daa359d/html5/thumbnails/28.jpg)
Thank you!
Special thanks to NCAIDS and NCWCH, China CDC
特别感谢国家性艾中心和国家妇幼保健中心
Dr. Wu Zunyou (NCAIDS Director)
WHO, UNICEF and UNAIDS
Staff of the US CDC’s Global AIDS Program in China
28